Anika Therapeutics
ANIK
ANIK
165 hedge funds and large institutions have $574M invested in Anika Therapeutics in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 55 increasing their positions, 50 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5.71% more ownership
Funds ownership: 93.75% → 99.46% (+5.7%)
5% more funds holding
Funds holding: 157 → 165 (+8)
Holders
165
Holding in Top 10
–
Calls
$4.6M
Puts
$832K
Top Buyers
| 1 | +$14.5M | |
| 2 | +$6.12M | |
| 3 | +$4.37M | |
| 4 |
D.E. Shaw & Co
New York
|
+$4.12M |
| 5 |
Natixis Advisors
Boston,
Massachusetts
|
+$4.11M |
Top Sellers
| 1 | -$6.22M | |
| 2 | -$3.69M | |
| 3 | -$3.52M | |
| 4 |
JG
Jefferies Group
New York
|
-$3.48M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.07M |